Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of tralokinumab plus topical corticosteroids in children and infants with moderate-to-severe atopic dermatiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Tralokinumab (tralokinumab)

Snippet

Sponsor: LEO Pharma | Conditions: Atopic Dermatitis | Phase 3 | Status: RECRUITING